Page last updated: 2024-10-28

hypericin and Thyroid Neoplasms

hypericin has been researched along with Thyroid Neoplasms in 2 studies

Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.

Research Excerpts

ExcerptRelevanceReference
"Thyroid cancer is the most common type of endocrine-related cancer."1.62Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction. ( Javidi, MA; Mehrparvar, B; Mohammadian, A; Piryaei, M; Shahriari, F, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Piryaei, M1
Mehrparvar, B1
Mohammadian, A1
Shahriari, F1
Javidi, MA1
Kim, H1
Kim, SW1
Seok, KH1
Hwang, CW1
Ahn, JC1
Jin, JO1
Kang, HW1

Other Studies

2 other studies available for hypericin and Thyroid Neoplasms

ArticleYear
Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction.
    European journal of pharmacology, 2021, Nov-05, Volume: 910

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Ce

2021
Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 24

    Topics: Animals; Anthracenes; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Hum

2018